Miguel X Escalon, MD
- ASSOCIATE PROFESSOR | Rehabilitation and Human Performance
- ASSOCIATE PROFESSOR | Medical Education
Specialty:Rehabilitation and Physical Medicine
Dr. Miguel Xavier Escalón is the Vice Chair of the Department of Rehabilitation and Human Performance. He came to The Icahn School of Medicine at Mount Sinai in 2013 and has served as Director of Critical Care Rehabilitation since 2014 and as the Residency Program Director for the PM&R residency since 2017. He also serves as the Director of Brain Injury Medicine at Mount Sinai and is the Fellowship Director for the Brain Injury Medicine Fellowship. He is an Associate Professor in the Department of Rehabilitation and Human Performance and the Department of Medical Education at the Icahn School of Medicine at Mount Sinai.
He received his undergraduate degree from The University of Chicago and his medical degree from University of Illinois. He received specialty training in Rehabilitation Medicine at The Baylor/UT-Houston PM&R Alliance.
Dr. Escalón is board certified in Physical Medicine and Rehabilitation, Spinal Cord Injury Medicine and Brain Injury Medicine.
Dr. Escalón works closely with physical therapists, occupational therapists, speech therapists, recreational therapists, neuropsychologists, and other medical and surgical specialists in order to provide comprehensive care.
Dr. Escalón oversees the rehabilitation and mobilization of critically ill patients, especially those patients in the ICU. The scope of his ICU practice includes debility, critical illness myopathy/polyneuropathy, pain, spasticity, delirium, early mobilization, etc.
Dr. Escalón also focuses on neuro-rehabilitation of any disease that affects the central nervous system (brain and spinal cord). He is an expert in spasticity management, including intrathecal pump management and botulinum toxin injections.
American Board of Physical Medicine and Rehab
- Amputation Prevention
- Amputation Rehabilitation
- Amyotrophic Lateral Sclerosis
- Botulinum Toxin Injections
- Cauda Equina Syndrome
- Central Cord Syndrome
- Cerebral Palsy
- Cervical Myelopathy
- Cervical Radiculopathy
- Guillain-Barré Syndrome
- Heterotopic Ossification
- Hyaluronate Injections
- Intracerebral Hemorrhage (ICH)
- Knee Pain
- Lumbar Radiculopathy
- Multiple Sclerosis
- Muscle Strain
- Muscular Dystrophy
- Musculoskeletal Rehabilitation
- Neurogenic Bladder
- Post-Polio Syndrome
- Postconcussion Syndrome
- Quadriplegia And Paraplegia
- Radiofrequency Ablation
- Regenerative Medicine
- Spina Bifida
- Spinal Cord Disorder
- Spinal Cord Injury
- Stem Cell Therapy
- Subarachnoid Hemorrhage
- Subdural Hematoma
- Traumatic Brain Injury
- Ultrasound-Guided Joint Injections
- Wheelchair Evaluations
MD, University of Pennsylvania School of Dental Medicine
MPH, University of Illinois at Chicago
Internship, Internal Medicine, OSF St. Francis Medical Center
Residency, Physical Medicine & Rehabilitation, Baylor College of Medicine
Fellowship, Spinal Cord Injury Medicine, Mount Sinai Hospital
Dr. Escalón is involved with research related to brain injury and spinal cord injury especially as it relates to pain, spasticity and recovery after injury as well as leveraging technology to optimize improvement post-injury. He is also involved in the use of robotic exoskeletons to facilitate walking for neurological recovery after spinal cord injury. Dr. Escalón is also involved in research related to ICU patients as it relates to their long term function and quality of life.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Escalon did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.